Sugar High: How a Glucose Monitor Told Me Startling Things About My Diet
Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...
Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in ...
drugdeliverybusiness1h
Dexcom, Retta, Beyond Type 2 team up to raise glucose awareness
Dexcom (Nasdaq:DXCM) today announced a collaboration to establish National Glucose Awareness Week from Sept. 23-29, 2024.
Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, ...
DexCom: Investors Discounting Long CGM Growth Runway
DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...
Researchers present ranges of normal glucose levels among non-diabetic adults wearing continuous glucose monitors
New continuous glucose monitoring sensors (small sensors that penetrate the skin to measure glucose levels in real time) are ...
EXCLUSIVE: Retta details the moment she was diagnosed with Type 2 diabetes
Retta reveals the first symptoms of her Type 2 diabetes. The actor shares the lifestyle changes she made and the glucose ...
Wells Fargo Sticks to Their Buy Rating for Dexcom (DXCM)
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of ...
Unpacking the Latest Options Trading Trends in DexCom
Today, Benzinga 's options scanner spotted 8 uncommon options trades for DexCom. This isn't normal. The overall sentiment of ...
Econsultancy4d
Dexcom expands Continuous Glucose Monitoring coverage to 14 million globally with help of integrated #SeeDiabetes campaign
The company, which manufactures CGM devices, partnered with Allison PR for a campaign that aimed to spread awareness of life ...
BioWorld5d
FDA clears Senseonic’s Eversense one-year implantable CGM
The U.S. FDA cleared Senseonic Holdings Inc.’s Eversense 365, the first continuous glucose monitor to last a full year with a single sensor rather than the 10 days to two weeks typical for wearable ...